Louis Edward Tamayo, Chief Financial Officer at Lexeo Therapeutics, Inc. (LXEO), sold 4,117 shares at $4.91 ($20K) on 2026-08-18, disclosed to the SEC on 2026-08-19.
Open-market sale of $20k LXEO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.